The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b/2 study evaluating the activity of tinengotinib in combination with androgen receptor pathway inhibitors (ARPIs) in patients with metastatic castration resistant prostate cancer (mCRPC).
 
Wassim Abida
Honoraria - Aptitude Health; Clinical Education Alliance; Medscape; OncLive/MJH Life Sciences; Pfizer; Roche; theMedNet; touchIME
Consulting or Advisory Role - AstraZeneca/MedImmune; Clovis Oncology; Daiichi Sankyo; Endeavor BioMedicines; Janssen; Laekna Therapeutics; MOMA Therapeutics; ORIC Pharmaceuticals; Pfizer
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Epizyme (Inst); Merus (Inst); Nuvation Bio (Inst); ORIC Pharmaceuticals (Inst); TransThera Biosciences (Inst); Zenith Epigenetics (Inst)
(OPTIONAL) Uncompensated Relationships - Nuvation Bio
 
Yu Chen
Stock and Other Ownership Interests - ORIC Pharmaceuticals
Honoraria - Belharra Therapeutics; FOGPharma
Research Funding - Foghorn Therapeutics
Patents, Royalties, Other Intellectual Property - invention related to glucocorticoid inhibitors for treatment of prostate cancer (SK2013-045),; invention related to glucocorticoid inhibitors for treatment of prostate cancer (SK2013-045),
 
Deaglan McHugh
Honoraria - OncLive
Consulting or Advisory Role - Progenics
 
Michael Morris
Employment - Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Ambrx; Amgen; Arvinas; Blue Earth Diagnostics; Bristol-Myers Squibb/Celgene; Clarity Pharmaceuticals; Convergent Therapeutics; Core Medica; Curium Pharma; Daiichi; Exelixis; Flare Therapeutics; Fusion Pharmaceuticals; ITM Isotope Technologies Munich; Lantheus Medical Imaging; Mashup Media; Pfizer; POINT Biopharma; Progenics; Telix Pharmaceuticals; Transtherabio; Z-Alpha
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; APCCC; AstraZeneca; Memorial Sloan-Kettering Cancer Center
(OPTIONAL) Uncompensated Relationships - Amgen; Bayer; Halda Therapeutics; Janssen Oncology; Novartis; Wren Laboraties
 
Frank Wu
Employment - TransThera Sciences (Nanjing), Inc.
Leadership - TransThera Sciences (Nanjing), Inc.
Stock and Other Ownership Interests - TransThera Sciences (Nanjing), Inc.
Research Funding - TransThera Sciences (Nanjing), Inc.
Patents, Royalties, Other Intellectual Property - I am an inventor of the patent during my employment but my company owns the patent
Travel, Accommodations, Expenses - TransThera Sciences (Nanjing), Inc.
 
Peng Peng
Employment - TransThera Sciences (Nanjing), Inc.
Stock and Other Ownership Interests - TransThera Sciences (Nanjing), Inc.
Patents, Royalties, Other Intellectual Property - PCT/CN2022/091924 (Inst)
 
Katie Hennessy
Employment - TransThera Biosciences
Travel, Accommodations, Expenses - TransThera Biosciences
 
Hui Wang
No Relationships to Disclose
 
Jean Fan
Employment - TransThera Biosciences
Leadership - TransThera Biosciences
Stock and Other Ownership Interests - AstraZeneca
 
Samir Zaidi
Consulting or Advisory Role - Gerson Lehrman Group; Guidepoint Global; TransThera Biosciences